Search results
Mirikizumab Shows Promise for Moderate to Severe Crohn's
Medscape· 1 day agoAlready approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for...
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial
MedPage Today· 1 day agoThe fully human monoclonal antibody pamrevlumab failed to improve lung function among patients with idiopathic pulmonary fibrosis (IPF) in the randomized ...
Q3 2024 EPS Estimates for Equillium, Inc. Boosted by HC Wainwright (NASDAQ:EQ)
ETF DAILY NEWS· 5 hours agoEquillium, Inc. (NASDAQ:EQ – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2024 earnings per share estimates for Equillium in a research report issued to clients and investors ...
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 2 days agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
Benzinga· 13 hours agoNOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 5 days agoA monoclonal antibody, solrikitug targets thymic stromal lymphopoietin. It will treat critical...
Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors
Morningstar· 6 days ago(Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the ...
Adagene Inc. (NASDAQ:ADAG) Short Interest Up 6.3% in April
ETF DAILY NEWS· 4 days agoAdagene Inc. (NASDAQ:ADAG – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase ...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 7 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 13 hours agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...